23 G better than 20 G

Article

The 23-gauge system for pars plana vitrectomy offers greater postoperative comfort for the patient than does the standard 20-gauge system, according to a study published online ahead of print by the British Journal of Ophthalmology.

The 23-gauge system for pars plana vitrectomy offers greater postoperative comfort for the patient than does the standard 20-gauge system, according to a study published online ahead of print by the British Journal of Ophthalmology.

Susanne Binder, of the Department of Ophthalmology at the Rudolph Foundation Clinic, Vienna, Austria, and colleagues conducted a prospective clinical trial comparing the outcomes of pars plana vitrectomy, in which the 60 subjects were randomized into two groups using either the 23- or the 20-gauge system.

The team noted that patients operated on with 23-gauge instruments experienced less postoperative pain and required fewer conjunctival injections than the group operated on with 20-gauge instruments. In addition, the 23-gauge group had shorter opening and closing times and longer vitrectomy times than the 20-gauge group, although postop visual acuity and intraocular pressure measurements did not differ between groups. Three adverse events were noted in the 23-gauge group, compared with none in the 20-gauge group.

Despite the increased incidence of adverse events, the team concluded that postoperative patient comfort is increased by the use of 23- rather than 20-gauge instruments.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.